Cardiac sympathetic activity in ischemic heart failure;Kardiale sympathikusaktivitat bei der ischamischen herzinsuffizienz

Zeitschrift fur Kardiologie

Volumn 87, Issue SUPPL. 2, 1998, Pages 33-36

  Richardt, G ^a   Hartmann, F ^a   Slotty, C ^a   Katus, H A ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

Heart failure; Myocardial ischemia; Norepinephrine; Sympathetic activity

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BRIMONIDINE; LOSARTAN; NORADRENALIN; YOHIMBINE;

ADRENERGIC SYSTEM; CONTROLLED STUDY; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; PATHOPHYSIOLOGY; REVIEW; CONGESTIVE HEART FAILURE; HEART; HEART MUSCLE ISCHEMIA; INNERVATION; PHYSIOLOGY; PROGNOSIS;

HEART; HEART FAILURE, CONGESTIVE; HUMANS; MYOCARDIAL ISCHEMIA; NOREPINEPHRINE; PROGNOSIS; SYMPATHETIC NERVOUS SYSTEM;

EID: 0031727314     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Cleland JGF, Bristow MR, Erdmann E, Remme WJ, Swedberg K, Waagstein F (1996) Beta-blocking agents in heart failure. Eur Heart J 17: 1629-1639
2. Cohn JN, Levine TB, Olivani MT, Garbery V, Lara D, Francis GS, Simon AB, Rector T (1984) Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 311: 819-823
3. Daly PA, Sole MJ (1990) Myocardial catecholamines and the pathophysiology of heart failure. Circulation 82 (Suppl I): I-35-I-43
4. Floras JS (1993) Clinical aspects of sympathetic activation and parasympathetic withdrawal in heart failure. J Am Coll Cardiol 22 (Suppl A): 72 A-84 A
5. Harding SE, Brown LA, Wynne DG, Davies CH, Poole-Wilson PA (1994) Mechanismus of beta-adrenoceptor desensitisation in the failing human heart. Cardiovascular Res 28: 1451-1460
6. Hartmann F, Ziegler S, Watzlowik P, Hadamitzki M, Richardt G, Schwaiger M (1995) Evidence of regional myocardial sympathetic denervation in dilated cardiomyopathy. Eur Heart J 16 (Suppl 16): 164
7. Hasking GJ, Esler DM, Jennings GL, Burton D, Korner I (1986) Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation 73: 615-621
8. Likoff MJ, Chandler SL, Kay HR (1987) Clinical determinants of mortality in chronic congestive heart failure secondary to idiopatic dilated or to ischemic cardiomyopathy. Am J Cardiol 59: 634-638
9. Meredith IT, Eisenhofer G, Lambert GW, Dewar EM, Jennings GL, Esler MD (1993) Cardiac sympathetic nervous activity in congestive heart failure. Circulation 88: 136-145
10. Münch G, Kurz T, Urlbauer T, Seyfarth M, Richardt G (1996) Differential presynaptic modulation of noradrenaline release in human atrial tissue in normoxia and anoxia. Br J Pharmacol 118: 1855-1861
11. Rundqvist B, Elam M, Bergmann-Sverrisdottir Y, Eisenhofer G, Friberg P (1997) Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure. Circulation 95: 169-175
12. Ungerer M, Hartmann F, Richardt G (1996) Das sympathoadrenerge System bei Herzinsuffizienz. Dtsch Med Wschr 121: 141-145
13. Ungerer M, Hartmann F, Karoglan M, Chlistalla A, Ziegler S, Richardt G, Overbeck M, Meissner F, Schömig A, Schwaiger M (1998) Regional in vivo and in vitro characterization of autonomic innervation in cardiomyopathic human heart. Circulation 97: 174-180
14. Yoshihawa T, Part JD, Asono K (1996) Cardiac adrenergic receptor effects of carvedilol. Eur Heart J 18 (Suppl B): 8-16